Taurus Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,753
Closed -$232K 88
2020
Q3
$232K Hold
1,753
0.03% 82
2020
Q2
$203K Buy
+1,753
New +$202K 0.03% 82
2020
Q1
Sell
-1,753
Closed -$255K 89
2019
Q4
$255K Hold
1,753
0.03% 85
2019
Q3
$234K Hold
1,753
0.03% 85
2019
Q2
$200K Hold
1,753
0.03% 86
2019
Q1
$217K Buy
+1,753
New +$199K 0.03% 90
2018
Q4
Sell
-1,753
Closed -$224K 98
2018
Q3
$224K Buy
+1,753
New +$208K 0.03% 95
2018
Q1
Sell
-1,753
Closed -$205K 112
2017
Q4
$205K Sell
1,753
-1,391
-44% -$157K 0.03% 103
2017
Q3
$357K Hold
3,144
0.06% 75
2017
Q2
$392K Buy
3,144
+1,391
+79% +$165K 0.06% 76
2017
Q1
$208K Buy
+1,753
New +$199K 0.03% 89
2016
Q4
Sell
-1,753
Closed -$221K 94
2016
Q3
$221K Hold
1,753
0.04% 90
2016
Q2
$205K Buy
+1,753
New +$198K 0.04% 88
2015
Q2
Sell
-1,753
Closed -$200K 93
2015
Q1
$200K Buy
+1,753
New +$200K 0.04% 90

Other funds holding ZBH

Taurus Asset Management's ZBH Position: Q4 2020 in Review

Taurus Asset Management sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 1,753 shares — an estimated $232K sold.

Taurus Asset Management first reported a position in ZBH in Q1 2015 and held it in 14 quarters. The position peaked at $392K in Q2 2017. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Taurus Asset Management reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Taurus Asset Management sold 1,753 Zimmer Biomet shares in Q4 2020, an estimated $232K.
  • Taurus Asset Management first reported a position in Zimmer Biomet in Q1 2015 and held it in 14 quarters.
  • Taurus Asset Management's Zimmer Biomet position peaked at $392K in Q2 2017.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Taurus Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.